31 results
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
and after marketing could reveal side effects that could delay, impede, or prevent FDA marketing approval, resulting in FDA-ordered product recall, or in FDA
424B3
RGBP
Regen BioPharma Inc
2 Oct 23
Prospectus supplement
1:42pm
, impede, or prevent FDA marketing approval, resulting in FDA-ordered product recall, or in FDA-imposed limitations on permissible
The FDA regulates
424B3
npb c2sqp
15 May 23
Prospectus supplement
10:25am
8-K
EX-10.1
k0dsltigyd nti9
8 Apr 21
Entry into a Material Definitive Agreement
10:08am
8-K
EX-10.2
6lwbmcuy2f8u88v51
8 Apr 21
Entry into a Material Definitive Agreement
10:08am